Clinical Trial Update: Influence of Atorvastatin on Psoriasis Severity and Endothelial Function [Phase 3]

View source ↗

Summary

A Phase 3 trial examining atorvastatin for psoriasis severity and endothelial function has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Lipitor (atorvastatin)

Snippet

Sponsor: shmuel fuchs | Conditions: Psoriasis | Phase 3 | Status: WITHDRAWN